3 Reasons to Sell GH and 1 Stock to Buy Instead [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
This run-up might have investors contemplating their next move. Is now the time to buy Guardant Health, or should you be careful about including it in your portfolio? See what our analysts have to say in our full research report, it's free Despite the momentum, we're sitting this one out for now. Here are three reasons why we avoid GH and a stock we'd rather own. Pioneering the field of "liquid biopsy" with technology that can identify cancer-specific genetic mutations from a simple blood draw, Guardant Health (NASDAQ:GH) develops blood tests that detect and monitor cancer by analyzing tumor DNA in the bloodstream, helping doctors make treatment decisions without invasive biopsies. We track the long-term change in earnings per share (EPS) because it highlights whether a company's growth is profitable. Guardant Health's earnings losses deepened over the last five years as its EPS dropped 19% annually. We'll keep a close eye on the company as diminishing earnings could imply c
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening [Yahoo! Finance]Yahoo! Finance
- Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth [Yahoo! Finance]Yahoo! Finance
- Guardant Health is the top performing healthcare services stock YTD [Seeking Alpha]Seeking Alpha
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at Canaccord Genuity Group Inc. from $100.00 to $125.00. They now have a "buy" rating on the stock.MarketBeat
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at Mizuho from $100.00 to $120.00. They now have an "outperform" rating on the stock.MarketBeat
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 12/23/25 - Form 4
- 12/18/25 - Form 4
- 12/18/25 - Form 4
- GH's page on the SEC website